The purpose of this study is to investigate metastatic pancreatic cancer. It examines how vitamin C affects the quality of life for patients with this condition.
This study evaluates the effectiveness of vitamin C in improving the well-being of patients. It looks at factors like quality of life, pain levels, and anemia in individuals resistant to certain chemotherapy treatments.
- Who can participate: Adults aged 18 to 80 with pancreatic adenocarcinoma who have not responded to two chemotherapy regimens may participate.
- Study details: Participants will receive vitamin C based on their blood levels. The study will monitor quality of life, pain, and anemia every four weeks.
How understandable was the trial content above?
Hard to understand
Easy to understand